André Luís de Godoy

André Luís de Godoy

Auto-generated profile, based on publicly available information

André Luís de Godoy

A.C. Camargo Cancer Center, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2014 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
FFFlávia H. Feier
Flávia H. Feier
PCPaulo Chapchap
Paulo Chapchap
RPRenata Pugliese
Renata Pugliese
EFEduardo A. da Fonseca
Eduardo A. da Fonseca
FCFrancisco C. Carnevale
Francisco C. Carnevale
JSJoão Seda-Neto
João Seda-Neto
The incidence of biliary complications (BCs) after living donor liver transplantation (LDLT) can reach 40%. Published data on the pediatric population are limited, and treatment protocols vary. Our aim was to describe the clinical scenario for BCs and treatment approaches after LDLT. Between October 1995 and December 2012, 489 pediatric LDLT procedures were performed. BCs developed in 71 patients (14.5%). Biliary strictures (BSs) developed in 45 (9.2%) patients, and bile leaks (BLs) developed in 33 patients (6.7%). The BL diagnosis was clinical in all cases, and 69.7% of the patients underwent surgery. Nearly half of the BS cases had clinical features or suggestive ultrasound findings. Liver biopsy findings suggested BSs in 51.7%. Percutaneous transhepatic cholangiography was performed in 95.6% of the BS patients. The success rate was 77% [mean number of percutaneous biliary interventions (PBIs) = 3.9 ± 1.98, median drainage time = 8 months]. In conclusion, BL patients can be managed with conservative therapy, even though most of these patients will ultimately be treated with surgery. Diagnosing a BS requires a high degree of clinical suspicion because the available resources for its identification can fail in up to 50% of cases. A higher number of PBIs and the use of a drainage catheter for a longer time may be required to achieve better results with this technique. Liver Transpl 20:882–892, 2014. © 2014 AASLD.

7 October 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
RPRenata Pugliese
Renata Pugliese
EFEduardo A. Fonseca
Eduardo A. Fonseca
GPGilda Porta
Gilda Porta
VDVera Danesi
Vera Danesi
TGTeresa Guimaraes
Teresa Guimaraes
JNJoao Seda Neto
Joao Seda Neto
Ascites is the most common complication of cirrhosis and in adults it is associated with 50% mortality at 5 years if patients do not receive a liver transplant. The occurrence of hyponatremia in these patients has been associated with increased mortality on the waiting list. The importance of serum sodium levels and the presence of ascites in the pediatric setting remain to be clarified. A retrospective analysis of pediatric patients with cirrhosis on the transplant list was carried out between October 2000 and February 2012. The primary objective of this study was to evaluate the association of pretransplant variables with mortality within 90 days following the inclusion of patients on the waiting list. In all, 522 patients were included in the study; 345 (66%) patients were under 1 year of age; 208 (40%) of the children presented ascites. A multivariate Cox proportional hazards analysis was conducted and total bilirubin ( P < 0.001, hazard ratio [HR] = 2.09, 95% confidence interval [CI] = 1.35-3.21), international normalized ratio (INR) ( P < 0.001, HR = 9.83, 95% CI = 4.51-21.45), serum sodium levels ( P = 0.03, HR = 0.96, 95% CI = 0.92-0.99), ascites ( P = 0.001, HR = 2.59, 95% CI = 1.44-4.64), and categorized age (0-1 versus ≥1 year old) ( P = 0.025, HR = 2.33, 95% CI = 1.11-4.86) were independently associated with risk of death in 90 days. Malnutrition (Z score height/age, weight/age) and serum albumin (pediatric endstage liver disease [PELD] formula) were not included in the final model. Conclusion : The presence of ascites and serum sodium levels are important variables associated with decreased patient survival while candidates wait for a liver graft. Multicenter studies are necessary to validate these findings in order to improve current allocation policies based on the PELD score. (Hepatology 2014;59:1964–1971)

1 October 2014 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
JNJoao Seda Neto
Joao Seda Neto
EFEduardo A. Fonseca
Eduardo A. Fonseca
FFFlávia H. Feier
Flávia H. Feier
RPRenata Pugliese
Renata Pugliese
HCHelry L. Candido
Helry L. Candido
PCPaulo Chapchap
Paulo Chapchap

1 April 2013 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
HRH.S.C. Ribeiro
H.S.C. Ribeiro
WCW.L. Costa
W.L. Costa
ADA.L. Diniz
A.L. Diniz
AGA.L. Godoy
A.L. Godoy
PHP. Herman
P. Herman
FCF.J.F. Coimbra
F.J.F. Coimbra

30 July 2007 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
JNJoao Seda Neto
Joao Seda Neto
ECEduardo Carone
Eduardo Carone
VPVincenzo Pugliese
Vincenzo Pugliese
ASAlcides Salzedas
Alcides Salzedas
EFEduardo A. Fonseca
Eduardo A. Fonseca
PCPaulo Chapchap
Paulo Chapchap
Infants with end-stage liver disease represent a treatment challenge. Living donor liver transplantation (LDLT) is the only option for timely liver transplantation in many areas of the world, adding to the technical difficulties of the procedure. Factors that affect morbidity and mortality can now be determined, which opens a new era for improvement. We have accumulated an 11-year experience with LDLT for children weighing <10 kg. From October 1995 to October 2006, a total of 222 LDLT in patients <18 years of age were performed; 129 primary LDLT and 7 retransplants (4 LDLT and 3 deceased donor grafts) were performed in 129 infants weighing 4%. Two patients received monosegmental grafts, and 2 patients underwent delayed abdominal wall closure. Portal vein thrombosis occurred in 5.4% of the patients, hepatic artery thrombosis in 3.1%, and both in 1.5%. Among several variables studied, only the bilirubin level at the time of transplantation was associated with increased risk of death (P = 0.009). Grafts with GRWR >4% had no negative effect on patient survival. There were 7 retransplants, and 4 patients received a second parental LDLT. Patient survival rates at 1, 3, and 10 years after transplantation were 88.8%, 84.7%, and 82% for all children, and 87.5%, 84.9%, and 84.9% for infants weighing <10 kg. LDLT has results comparable to other modalities of liver transplantation in infants. Monosegment grafts were rarely required in this series, although they may be necessary in patients with lower body weight. Liver Transpl 13:1153–1158, 2007. © 2007 AASLD.

15 December 2009 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
JNJoao Seda Neto
Joao Seda Neto
ECEduardo Carone
Eduardo Carone
RPRenata P. S. Pugliese
Renata P. S. Pugliese
EFEduardo A. Fonseca
Eduardo A. Fonseca
GPGilda Porta
Gilda Porta
PCPaulo Chapchap
Paulo Chapchap
The Pediatric End-Stage Liver Disease (PELD) scoring system is a formula developed to provide a continuous numerical assessment of the risk of death in order to allocate livers to children in need of transplantation. The PELD scoring system was introduced in Brazil in July 2006. An important change was made in the system: the final number for listing patients less than 12 years old for transplantation was the calculated PELD score multiplied by 3. The consequences of this allocation policy were analyzed in 2 ways in this research: nationally and in the state of São Paulo (SP State). In the analysis of the national data, a comparison of the pre-PELD era (July 2003 to July 2006) and the post-PELD era (August 2006 to April 2009) showed that the total number of pediatric transplants for children under 12 years of age decreased 7%. Regionally, in SP State, there was a 62% increase in the number of deceased donor liver transplantation procedures for the pediatric population after the introduction of the modified PELD system. There was also a 6.1-fold increase in split liver transplantation as well as a statistically significant decrease in the time on the waiting list (P < 0.001). In conclusion, changing the allocation policy in Brazil in order to benefit pediatric patients on the waiting list had different results according to analyses of national and regional data. A significant increase in deceased donor liver transplantation/split liver transplantation and a shorter time on the waiting list were observed in SP State. The modified PELD scoring system is simple and optimizes the utilization of deceased donor liver grafts in centers performing pediatric transplants.